Clearstead Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $283K | Sell |
5,003
-1,184
| -19% | -$69K | ﹤0.01% | 883 |
|
|
2025
Q4 | $368K | Buy |
6,187
+2,733
| +79% | +$149K | ﹤0.01% | 755 |
|
|
2025
Q3 | $187K | Buy |
3,454
+1,304
| +61% | +$74.6K | ﹤0.01% | 896 |
|
|
2025
Q2 | $118K | Buy |
2,150
+656
| +44% | +$38.6K | ﹤0.01% | 1016 |
|
|
2025
Q1 | $106K | Buy |
1,494
+1,243
| +495% | +$83.6K | ﹤0.01% | 985 |
|
|
2024
Q4 | $16.5K | Hold |
251
| – | – | ﹤0.01% | 1446 |
|
|
2024
Q3 | $17.6K | Sell |
251
-266
| -51% | -$22.2K | ﹤0.01% | 1456 |
|
|
2024
Q2 | $42.6K | Buy |
517
+266
| +106% | +$22.1K | ﹤0.01% | 1202 |
|
|
2024
Q1 | $20.2K | Sell |
251
-196
| -44% | -$17.5K | ﹤0.01% | 944 |
|
|
2023
Q4 | $43.1K | Sell |
447
-7,313
| -94% | -$647K | ﹤0.01% | 782 |
|
|
2023
Q3 | $687K | Buy |
7,760
+3,880
| +100% | +$345K | 0.02% | 358 |
|
|
2023
Q2 | $336K | Buy |
3,880
+231
| +6% | +$21.7K | 0.02% | 348 |
|
|
2023
Q1 | $355K | Hold |
3,649
| – | – | 0.03% | 314 |
|
|
2022
Q4 | $378K | Hold |
3,649
| – | – | 0.03% | 292 |
|
|
2022
Q3 | $309K | Hold |
3,649
| – | – | 0.03% | 302 |
|
|
2022
Q2 | $302K | Hold |
3,649
| – | – | 0.02% | 318 |
|
|
2022
Q1 | $281K | Buy |
3,649
+3,613
| +10,036% | +$302K | 0.02% | 358 |
|
|
2021
Q4 | $3K | Buy |
36
+18
| +100% | +$1.49K | ﹤0.01% | 1052 |
|
|
2021
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q2 | $2K | Sell |
18
-20
| -53% | -$1.58K | ﹤0.01% | 1023 |
|
|
2021
Q1 | $3K | Buy |
38
+25
| +192% | +$2.04K | ﹤0.01% | 911 |
|
|
2020
Q4 | $1K | Buy |
+13
| New | +$1.03K | ﹤0.01% | 917 |
|
Other funds holding BMRN
VCM
VPM
